Walgreens #19694 - Medicare Supplier in Forest Hills, NY

Walgreens #19694 is a medicare enrolled Durable Medical Equipment & Medical Supplies Supplier in Forest Hills, New York. It is located at 11088 Queens Blvd, Forest Hills, New York 11375. You can reach out to the office of Walgreens #19694 via phone at (718) 275-5252. Walgreens #19694 supplies medicare equipments and products such as Ostomy Supplies, Heat & Cold Applications, Enteral Nutrients, Commodes, Urinals, & Bedpans, Canes & Crutches, Blood Glucose Monitors & Supplies: Non-Mail Order, etc. The legal business name for Walgreens #19694 is Walgreen Co.

Contact Information

Walgreens #19694
11088 Queens Blvd, Forest Hills, New York 11375
(718) 275-5252


Supplier Profile

NameWalgreens #19694
Organization NameWalgreen Co
Location11088 Queens Blvd, Forest Hills, New York 11375
TypeDurable Medical Equipment & Medical Supplies Supplier
Phone(718) 275-5252
Participate in MedicareMedicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier.

News Archive

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

The Company's net loss for the quarter ended October 31, 2009 amounted to $2.5 million or ($0.01) per share, compared to $10.9 million or ($0.04) per share, for the quarter ended October 31, 2008.

Democrats and reform advocates lash back at insurers

Reactions and Democratic push back are beginning to be evident after the release Monday of an insurance industry-sponsored report (.pdf) that warns premiums could wind up costing $4,000 more by the end of decade if a proposed health overhaul is implemented, the Associated Press reports. The report isn't "worth the paper it's written on," AARP Executive Vice President John Rother said. The retiree's association has supported health reform (Alonso-Zaldivar and Werner, 10/12).

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world's most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.

Seasonal influenza and COVID-19 risk

In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).

The egg decides which sperm fertilizes it

There is ample evidence to show that as millions of human sperm cells swim towards a waiting ovum or egg, only one gets to fertilize it. Now, a new study shows that even though the fastest and most capable sperms reach the ovum first, it is the egg that has the final say on which sperm fertilizes it. The study titled, "Chemical signals from eggs facilitate cryptic female choice in humans," is published in the latest issue of the journal Proceedings of the Royal Society B.

Read more Medical News

› Verified 6 days ago

Products, Equipments, Supplies available at this Supplier:

Walgreens #19694 supplies following medicare products, supplies and equipments -
  • Blood Glucose Monitors & Supplies: Non-Mail Order
  • Canes & Crutches
  • Commodes, Urinals, & Bedpans
  • Enteral Nutrients
  • Heat & Cold Applications
  • Ostomy Supplies
  • Surgical Dressings
  • Urological Supplies
  • Walkers

NPI Associated with this Supplier:

Suppliers may have multiple NPI numbers. We have found possible NPI number/s associated with Walgreens #19694 from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1730605411
Organization NameWALGREEN CO
Doing Business AsWALGREENS #19694
TypeDurable Medical Equipment & Medical Supplies Supplier
Address11088 Queens Blvd, Forest Hills, NY 11375
Phone Number718-275-5252

News Archive

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

The Company's net loss for the quarter ended October 31, 2009 amounted to $2.5 million or ($0.01) per share, compared to $10.9 million or ($0.04) per share, for the quarter ended October 31, 2008.

Democrats and reform advocates lash back at insurers

Reactions and Democratic push back are beginning to be evident after the release Monday of an insurance industry-sponsored report (.pdf) that warns premiums could wind up costing $4,000 more by the end of decade if a proposed health overhaul is implemented, the Associated Press reports. The report isn't "worth the paper it's written on," AARP Executive Vice President John Rother said. The retiree's association has supported health reform (Alonso-Zaldivar and Werner, 10/12).

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world's most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.

Seasonal influenza and COVID-19 risk

In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).

The egg decides which sperm fertilizes it

There is ample evidence to show that as millions of human sperm cells swim towards a waiting ovum or egg, only one gets to fertilize it. Now, a new study shows that even though the fastest and most capable sperms reach the ovum first, it is the egg that has the final say on which sperm fertilizes it. The study titled, "Chemical signals from eggs facilitate cryptic female choice in humans," is published in the latest issue of the journal Proceedings of the Royal Society B.

Read more Medical News

› Verified 6 days ago


NPI Number1932208295
Organization NameGENOVESE DRUG STORES INC
Doing Business AsRITE AID PHARMACY 10599
TypeDurable Medical Equipment & Medical Supplies Supplier
Address11088 Queens Boulevard, Forest Hills, NY 11375
Phone Number718-275-5252

News Archive

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

The Company's net loss for the quarter ended October 31, 2009 amounted to $2.5 million or ($0.01) per share, compared to $10.9 million or ($0.04) per share, for the quarter ended October 31, 2008.

Democrats and reform advocates lash back at insurers

Reactions and Democratic push back are beginning to be evident after the release Monday of an insurance industry-sponsored report (.pdf) that warns premiums could wind up costing $4,000 more by the end of decade if a proposed health overhaul is implemented, the Associated Press reports. The report isn't "worth the paper it's written on," AARP Executive Vice President John Rother said. The retiree's association has supported health reform (Alonso-Zaldivar and Werner, 10/12).

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world's most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.

Seasonal influenza and COVID-19 risk

In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).

The egg decides which sperm fertilizes it

There is ample evidence to show that as millions of human sperm cells swim towards a waiting ovum or egg, only one gets to fertilize it. Now, a new study shows that even though the fastest and most capable sperms reach the ovum first, it is the egg that has the final say on which sperm fertilizes it. The study titled, "Chemical signals from eggs facilitate cryptic female choice in humans," is published in the latest issue of the journal Proceedings of the Royal Society B.

Read more Medical News

› Verified 6 days ago

News Archive

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

The Company's net loss for the quarter ended October 31, 2009 amounted to $2.5 million or ($0.01) per share, compared to $10.9 million or ($0.04) per share, for the quarter ended October 31, 2008.

Democrats and reform advocates lash back at insurers

Reactions and Democratic push back are beginning to be evident after the release Monday of an insurance industry-sponsored report (.pdf) that warns premiums could wind up costing $4,000 more by the end of decade if a proposed health overhaul is implemented, the Associated Press reports. The report isn't "worth the paper it's written on," AARP Executive Vice President John Rother said. The retiree's association has supported health reform (Alonso-Zaldivar and Werner, 10/12).

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world's most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.

Seasonal influenza and COVID-19 risk

In a new study published on the preprint server medRxiv, researchers from Laval University and McGill University in Canada reviewed evidence from 18 relevant studies on a possible interaction between influenza vaccines on non-influenza respiratory disease (NIRD).

The egg decides which sperm fertilizes it

There is ample evidence to show that as millions of human sperm cells swim towards a waiting ovum or egg, only one gets to fertilize it. Now, a new study shows that even though the fastest and most capable sperms reach the ovum first, it is the egg that has the final say on which sperm fertilizes it. The study titled, "Chemical signals from eggs facilitate cryptic female choice in humans," is published in the latest issue of the journal Proceedings of the Royal Society B.

Read more News

› Verified 6 days ago


Suppliers in Forest Hills, NY

Active Therapy Supply, Inc.
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 10121 Metropolitan Ave, Forest Hills, New York 11375
Phone: (718) 544-2850    
Cort Pharmacy Inc
Type: Pharmacy
Location: 6425 108th St, Forest Hills, New York 11375
Phone: (718) 897-2569    
Custom Rx Pharmacy Llc
Type: Community/Retail Pharmacy
Location: 102-03a Queens Blvd, Forest Hills, New York 11375
Phone: (718) 830-4500    
Cvs Pharmacy
Type: Durable Medical Equipment & Medical Supplies Supplier
Location: 118-10 Queens Blvd, Forest Hills, New York 11375
Phone: (718) 520-4530    
Cvs Pharmacy # 02057
Type: Pharmacy
Location: 100-02 Queens Blvd, Forest Hills, New York 11375
Phone: (718) 520-2334    

Medicare Suppliers

Durable Medical Equipment & Medical Supplies

Also referred to as DME Suppliers. A supplier of medical equipment such as respirators, wheelchairs, home dialysis systems, or monitoring systems, that are prescribed by a physician for a patient's use in the home and that are usable for an extended period of time.

Community/Retail Pharmacy

A pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers; administer vaccinations; and provide other professional services associated with pharmaceutical care.

Prosthetic/Orthotic Supplier

An organization that provides prosthetic and orthotic care which may include, but is not limited to, patient evaluation, prosthesis or orthosis design, fabrication, fitting and modification to treat limb loss for purposes of restoring physiological function and/or cosmesis or to treat a neuromusculoskeletal disorder or acquired condition.


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.